Bryant KL, Stalnecker CA, Zeitouni D, Klomp JE, Peng S, Tikunov AP, Gunda V, Pierobon M, Waters AM, George SD, Tomar G, Papke B, Hobbs GA, Yan L, Hayes TK, Diehl JN, Goode GD, Chaika NV, Wang Y, Zhang GF, Witkiewicz AK, Knudsen ES, Petricoin EF 3rd, Singh PK, Macdonald JM, Tran NL, Lyssiotis CA, Ying H, Kimmelman AC, Cox AD, Der CJ. Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. 2020 Jun;26(6):982. doi: 10.1038/s41591-020-0947-8. Erratum for: Nat Med. 2019 Apr;25(4):628-640. PMID: 32483362.
Stalnecker CA, Der CJ. RAS, wanted dead or alive: Advances in targeting RAS mutant cancers. Sci Signal. 2020 Mar 24;13(624):eaay6013. doi: 10.1126/scisignal.aay6013. PMID: 32209699; PMCID: PMC7393681.
Li Y, Ramachandran S, Nguyen TT, Stalnecker CA, Cerione RA, Erickson JW. The activation loop and substrate-binding cleft of glutaminase C are allosterically coupled. J Biol Chem. 2020 Jan 31;295(5):1328-1337. doi: 10.1074/jbc.RA119.010314. Epub 2019 Dec 23. PMID: 31871054; PMCID: PMC6996896.
Greene KS, Lukey MJ, Wang X, Blank B, Druso JE, Lin MJ, Stalnecker CA, Zhang C, Negrón Abril Y, Erickson JW, Wilson KF, Lin H, Weiss RS, Cerione RA. SIRT5 stabilizes mitochondrial glutaminase and supports breast cancer tumorigenesis. Proc Natl Acad Sci U S A. 2019 Dec 16;116(52):26625–32. doi: 10.1073/pnas.1911954116. Epub ahead of print. PMID: 31843902; PMCID: PMC6936584.
Bryant KL, Stalnecker CA, Zeitouni D, Klomp JE, Peng S, Tikunov AP, Gunda V, Pierobon M, Waters AM, George SD, Tomar G, Papke B, Hobbs GA, Yan L, Hayes TK, Diehl JN, Goode GD, Chaika NV, Wang Y, Zhang GF, Witkiewicz AK, Knudsen ES, Petricoin EF 3rd, Singh PK, Macdonald JM, Tran NL, Lyssiotis CA, Ying H, Kimmelman AC, Cox AD, Der CJ. Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer. Nat Med. 2019 Apr;25(4):628-640. doi: 10.1038/s41591-019-0368-8. Epub 2019 Mar 4. Erratum in: Nat Med. 2020 Jun;26(6):982. PMID: 30833752; PMCID: PMC6484853.
